Search research articles
Contact Us
Filters
Showing results (571-580 of 757) with videos related to
Page
of 76
Sort By:
Ugeskrift for Laeger
|
August 2, 1993
[No increase in the prevalence of vertebral fractures among postmenopausal women over a 10-year period]
M A Hansen, K Overgaard, V A Nielsen, et al.
Journal of Thrombosis and Haemostasis : JTH
|
January 18, 2006
A prospective study of anticardiolipin antibodies as a risk factor for venous thrombosis in a general population (the HUNT study)
I A Naess, S C Christiansen, S C Cannegieter, et al.
Maturitas
|
November 1, 1987
Climacteric symptoms after oral and percutaneous hormone replacement therapy
P B Jensen, J Jensen, B J Riis, et al.
Clinical Endocrinology
|
July 1, 1992
Effect of menopause and hormone replacement therapy on urinary excretion of pyridinium cross-links: a longitudinal and cross-sectional study
C Hassager, A Colwell, A M Assiri, et al.
Atherosclerosis
|
January 4, 2001
Raloxifene and estrogen reduces progression of advanced atherosclerosis--a study in ovariectomized, cholesterol-fed rabbits
N H Bjarnason, J Haarbo, I Byrjalsen, et al.
JAMA
|
May 19, 2005
Thrombophilia, clinical factors, and recurrent venous thrombotic events
Sverre C Christiansen, Suzanne C Cannegieter, Ted Koster, et al.
European Journal of Clinical Investigation
|
August 1, 1980
Prevention of early postmenopausal bone loss: controlled 2-year study in 315 normal females
C Christiansen, M S Christensen, P McNair, et al.
Acta Endocrinologica
|
June 1, 1990
Vitamin D metabolism in osteoporotic women during treatment with estrogen, an anabolic steroid, or calcitonin
D Hartwell, C Hassager, K Overgaard, et al.
The American Journal of Clinical Nutrition
|
July 1, 1985
Bone mineral and vitamin D in Aleutian Islanders
R B Mazess, H S Barden, C Christiansen, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 1, 1988
The effect of a gonadotropin-releasing hormone agonist analog (nafarelin) on bone metabolism
J S Johansen, B J Riis, C Hassager, et al.
Page
of 76
Search research articles
Search
Showing results (571-580 of 757) with videos related to
Sort By:
Page
of 76
Ugeskrift for Laeger
|
August 2, 1993
[No increase in the prevalence of vertebral fractures among postmenopausal women over a 10-year period]
M A Hansen, K Overgaard, V A Nielsen, et al.
Journal of Thrombosis and Haemostasis : JTH
|
January 18, 2006
A prospective study of anticardiolipin antibodies as a risk factor for venous thrombosis in a general population (the HUNT study)
I A Naess, S C Christiansen, S C Cannegieter, et al.
Maturitas
|
November 1, 1987
Climacteric symptoms after oral and percutaneous hormone replacement therapy
P B Jensen, J Jensen, B J Riis, et al.
Clinical Endocrinology
|
July 1, 1992
Effect of menopause and hormone replacement therapy on urinary excretion of pyridinium cross-links: a longitudinal and cross-sectional study
C Hassager, A Colwell, A M Assiri, et al.
Atherosclerosis
|
January 4, 2001
Raloxifene and estrogen reduces progression of advanced atherosclerosis--a study in ovariectomized, cholesterol-fed rabbits
N H Bjarnason, J Haarbo, I Byrjalsen, et al.
JAMA
|
May 19, 2005
Thrombophilia, clinical factors, and recurrent venous thrombotic events
Sverre C Christiansen, Suzanne C Cannegieter, Ted Koster, et al.
European Journal of Clinical Investigation
|
August 1, 1980
Prevention of early postmenopausal bone loss: controlled 2-year study in 315 normal females
C Christiansen, M S Christensen, P McNair, et al.
Acta Endocrinologica
|
June 1, 1990
Vitamin D metabolism in osteoporotic women during treatment with estrogen, an anabolic steroid, or calcitonin
D Hartwell, C Hassager, K Overgaard, et al.
The American Journal of Clinical Nutrition
|
July 1, 1985
Bone mineral and vitamin D in Aleutian Islanders
R B Mazess, H S Barden, C Christiansen, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 1, 1988
The effect of a gonadotropin-releasing hormone agonist analog (nafarelin) on bone metabolism
J S Johansen, B J Riis, C Hassager, et al.
Page
of 76